β Cell Hypoxia-Inducible Factor-1α Is Required for the Prevention of Type 1 Diabetes

Amit Lalwani; Joanna Warren; David Liuwantara; Wayne J. Hawthorne; Philip J. O’Connell; Frank J. Gonzalez; Rebecca A. Stokes; Jennifer Chen; D. Ross Laybutt; Maria E. Craig; Michael M. Swarbrick; Cecile King; Jenny E. Gunton

β Cell Hypoxia-Inducible Factor-1α Is Required for the Prevention of Type 1 Diabetes

2019

Summary: The development of autoimmune disease type 1 diabetes (T1D) is determined by both genetic background and environmental factors. Environmental triggers include RNA viruses, particularly coxsackievirus (CV), but how they induce T1D is not understood. Here, we demonstrate that deletion of the transcription factor hypoxia-inducible factor-1α (HIF-1α) from β cells increases the susceptibility of non-obese diabetic (NOD) mice to environmentally triggered T1D from coxsackieviruses and the β cell toxin streptozotocin. Similarly, knockdown of HIF-1α in human islets leads to a poorer response to coxsackievirus infection. Studies in coxsackievirus-infected islets demonstrate that lack of HIF-1α leads to impaired viral clearance, increased viral load, inflammation, pancreatitis, and loss of β cell mass. These findings show an important role for β cells and, specifically, lack of β cell HIF-1α in the development of T1D. These data suggest new strategies for the prevention of T1D. : Lalwani et al. describe a role for β cell hypoxia-inducible factor-1α (HIF1a) in determining whether β cell injury is followed by resolution and normal function or ongoing injury, autoimmunity, and type 1 diabetes. Keywords: type 1 diabetes, coxsackievirus, beta-cell, apoptosis, autoimmunity, streptozotocin, inflammation

Показать больше [+]